Results 181 to 190 of about 78,101 (219)
Leucine degradation metabolite ratio as a measure of meropenem susceptibility in carbapenem-resistant <i>Klebsiella pneumoniae</i>. [PDF]
Microbiol SpectrDixon B +5 more
europepmc +1 more source
Intra-abdominal infections caused by <i>Achromobacter xylosoxidans</i>: a systematic review. [PDF]
Ann Med Surg (Lond)Thiriveedi M +4 more
europepmc +1 more source
Gram-negative bloodstream infections in pediatric patients: antimicrobial resistance and factors associated with mortality. [PDF]
Front PediatrAkar A, Pişirici M.
europepmc +1 more source
A novel meropenem dosing strategy for Outpatient Parenteral Antimicrobial Therapy (OPAT): a pilot pharmacokinetic/pharmacodynamic study in non-critically ill patients. [PDF]
Antimicrob Agents ChemotherBriquet C +9 more
europepmc +1 more source
Pharmacokinetic analysis of nacubactam, a novel β-lactamase inhibitor, co-administered with meropenem in patients with a complicated urinary tract infection. [PDF]
JAC Antimicrob ResistMorita J +7 more
europepmc +1 more source
Meropenem / Meropenem-vaborbactam
, 2017 Meropenem is a broad-spectrum parenteral carbapenem with antimicrobial activity against a wide range of Gramnegative and Gram-positive bacteria, including anaerobes. As a consequence of emerging multidrug resistance, especially in Gram-negative organisms, the clinical reliance on meropenem and other carbapenems increased after their introduction ...
Peleg, A. Y., Harris, P.
openaire +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches: